SHL Medical, a Swiss provider of self-injection solutions, announced on Thursday that it is planning to establish SHL Advantec, a sub-group dedicated to providing tooling and automation solutions to the healthcare sector and other industries.
SHL Advantec will be headquartered in Zug, Switzerland and will commence operations with more than 600 employees across its offices and production sites in Switzerland, China, Taiwan, Mexico and the United States.
SHL Medical's existing tooling and automation operations will be integrated into SHL Advantec, bringing its range of technologies, services and equipment portfolio to the new business. Together with SHL Medical's recent strategic acquisitions -- Swiss-based LCA Automation and SMC Mould Innovation and US-based Superior Tooling -- SHL Advantec will form a global operations network spanning three continents to deliver faster support and shorter supply chain services to SHL Advantec's diverse customer base. Leveraging its experience in medical devices and other industries, SHL Advantec says that it will focus on helping its customers advance production quality and resilience while continuing to support SHL Medical's growth in autoinjector manufacturing.
Abbott and NACHC launch nationwide Food for Health initiative
Galmed reports positive preclinical results for Aramchol in prostate cancer
Galderma receives EU approval for Restylane Shaype facial shaping injectable
Sisram Medical introduces Titanium Prime treatment concept in Hong Kong SAR
Proteotype unveils Alchemi platform for blood-based multi-cancer test Enlighten
Insulet expands European footprint with Omnipod 5 and Omnipod Discover launch in Spain
Frontier IP portfolio company InSignals wins EU grant and launches Parkinson's app
PharmaResearch to acquire CG USA to support North American expansion of REJURAN Cosmetics
United Therapeutics wins FDA approval for LungFX ex vivo lung perfusion device